An Open-label, Multiple-dosing, Two-arms, One-sequence Study to Evaluate the Safety and Pharmacokinetics After Co-administration of Exforge (Amlodipine Besylate/Valsartan) and Lipitor (Atorvastatin Ca) in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 14 Sep 2017
Price : $35 *
At a glance
- Drugs Amlodipine/valsartan (Primary) ; Atorvastatin (Primary)
- Indications Cardiovascular disorders; Diabetic nephropathies; Dyslipidaemias; Hypertension
- Focus Pharmacokinetics
- Sponsors CJ Cheiljedang Corp.
- 11 Sep 2017 Status changed from not yet recruiting to completed.
- 03 Mar 2014 New trial record